Credit Suisse Ag Pacira Bio Sciences, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 74,728 shares of PCRX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,728

Previous 72,875 2.54%

Holding current value

$1.57 Million

Previous $2.46 Million 11.19%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.7 - $35.48 $51,328 - $65,744	1,853 Added 2.54%	74,728 $2.18 Million
Q4 2023 Feb 08, 2024	BUY	$26.32 - $34.31 $512,739 - $668,393	19,481 Added 36.49%	72,875 $2.46 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $75,319 - $98,420	-2,455 Reduced 4.4%	53,394 $1.64 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $47.5 $24,381 - $32,062	675 Added 1.22%	55,849 $2.24 Million
Q1 2023 May 10, 2023	BUY	$35.53 - $43.38 $36,205 - $44,204	1,019 Added 1.88%	55,174 $2.25 Million

Q4 2022 Feb 13, 2023	BUY	$38.19 - $57.45 $270,958 - $407,607	7,095 Added 15.08%	54,155 $2.09 Million
Q3 2022 Nov 10, 2022	BUY	$51.24 - $58.89 $85,980 - $98,817	1,678 Added 3.7%	47,060 $2.5 Million
Q2 2022 Aug 12, 2022	SELL	$51.49 - $81.64 $313,625 - $497,269	-6,091 Reduced 11.83%	45,382 $2.65 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $405,202 - $516,307	6,750 Added 15.09%	51,473 $3.93 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $957,721 - $1.24 Million	-19,965 Reduced 30.86%	44,723 $2.69 Million
Q3 2021 Nov 12, 2021	BUY	$54.64 - $61.3 $712,724 - $799,597	13,044 Added 25.26%	64,688 $3.62 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $275,837 - $326,223	4,661 Added 9.92%	51,644 $3.14 Million
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $1.25 Million - $1.65 Million	-20,993 Reduced 30.88%	46,983 $3.29 Million
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $1.41 Million - $1.86 Million	28,009 Added 70.08%	67,976 $4.07 Million
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $1.74 Million - $2.1 Million	-33,392 Reduced 45.52%	39,967 $2.4 Million
Q2 2020 Aug 12, 2020	SELL	$30.8 - $52.47 $544,236 - $927,144	-17,670 Reduced 19.41%	73,359 $3.85 Million
Q1 2020 May 13, 2020	SELL	$28.4 - $50.7 $211,807 - $378,120	-7,458 Reduced 7.57%	91,029 $3.05 Million
Q4 2019 Feb 12, 2020	BUY	$36.31 - $46.83 $2.31 Million - $2.98 Million	63,626 Added 182.51%	98,487 $4.46 Million
Q3 2019 Nov 12, 2019	SELL	$35.66 - $44.99 $1.51 Million - $1.9 Million	-42,281 Reduced 54.81%	34,861 $1.33 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $2.03 Million - $2.66 Million	-55,375 Reduced 41.79%	77,142 $3.36 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $3.49 Million - $4.04 Million	95,778 Added 260.7%	132,517 $5.04 Million
Q4 2018 Feb 13, 2019	SELL	$41.31 - $52.16 $12,888 - $16,273	-312 Reduced 0.84%	36,739 $1.58 Million
Q3 2018 Nov 13, 2018	SELL	$32.85 - $52.0 $144,211 - $228,280	-4,390 Reduced 10.59%	37,051 $1.82 Million
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $95,067 - $137,588	-3,457 Reduced 7.7%	41,441 $1.33 Million
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $868,670 - $1.34 Million	-28,975 Reduced 39.22%	44,898 $1.4 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $965,373 - $1.42 Million	30,310 Added 69.58%	73,873 $3.37 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $673,801 - $745,523	18,874 Added 76.45%	43,563 $1.64 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,689	24,689 $1.18 Million

Others Institutions Holding PCRX

# of Institutions

287

Shares Held

48.7M

Call Options Held

156K

Put Options Held

623K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $965M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account